Laboratory of Microbiology, Department of Biochemistry and Microbiology, Ghent University, K. L, Ledeganckstraat 35, 9000, Ghent, Belgium.
Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland.
Antonie Van Leeuwenhoek. 2022 Apr;115(4):461-472. doi: 10.1007/s10482-022-01712-0. Epub 2022 Feb 2.
We present polyphasic taxonomic data to demonstrate that strain 125703-2019, a human blood isolate, represents a novel species within the genus Pseudoclavibacter, and to reclassify the illegitimate Zimmermannella alba Lin et al., 2004 as Pseudoclavibacter albus comb. nov. Upon primary isolation, strain 125703-2019 could not be identified reliably using MALDI-TOF mass spectrometry during routine diagnostic work, but partial 16S rRNA gene sequence analysis revealed that it belonged to the genus Pseudoclavibacter. Average nucleotide identity and digital DNA-DNA hybridisation analyses confirmed that it represented a novel species within this genus. A detailed physiological characterisation yielded differential tests between the novel species and its nearest neighbor taxa, which could also be differentiated using MALDI-TOF mass spectrometry. We propose to formally classify this strain into the novel species Pseudoclavibacter triregionum sp. nov., with strain 125703-2019 (= R-76471, LMG 31777, CCUG 74796) as the type strain. The whole-genome assembly of strain 125703-2019 has a size of 2.4 Mb and a G + C content of 72.74%. A Pseudoclavibacter pangenome analysis revealed that 667 gene clusters were exclusively present in strain 125703-2019. While these gene clusters were enriched in several COG functional categories, this analysis did not reveal functions that explained the occurrence of this species in human infection. Finally, several phylogenetic and phylogenomic analyses demonstrated that the genus Pseudoclavibacter is polyphyletic with Pseudoclavibacter soli and Pseudoclavibacter caeni representing a unique and deeply branching line of descent within the family Microbacteriaceae. We therefore also propose to reclassify both species into the novel genus Caespitibacter gen. nov. as Caespitibacter soli comb. nov. and Caespitibacter caeni comb. nov., respectively, and with C. soli comb. nov. as the type species.
我们呈现多相分类数据,以证明菌株 125703-2019,一种人血分离株,代表假棒杆菌属中的一个新种,并将非法的齐默尔曼菌属 alba Lin 等人重新分类。2004 年作为假白杆菌属 comb。nov。在初步分离时,菌株 125703-2019 在常规诊断工作中不能可靠地使用 MALDI-TOF 质谱进行鉴定,但部分 16S rRNA 基因序列分析表明它属于假棒杆菌属。平均核苷酸同一性和数字 DNA-DNA 杂交分析证实,它代表了该属内的一个新种。详细的生理特征分析得出了新种与其最接近的分类群之间的差异试验,这些试验也可以使用 MALDI-TOF 质谱进行区分。我们建议将该菌株正式归类为新种假三地区杆菌 sp。nov.,以菌株 125703-2019(=R-76471、LMG 31777、CCUG 74796)为模式株。菌株 125703-2019 的全基因组组装大小为 2.4 Mb,G+C 含量为 72.74%。假棒杆菌属泛基因组分析显示,有 667 个基因簇仅存在于菌株 125703-2019 中。虽然这些基因簇在几个 COG 功能类别中富集,但该分析并未揭示出解释该物种在人类感染中存在的功能。最后,几种系统发育和系统基因组分析表明,假棒杆菌属是多系的,假棒杆菌属 soli 和假棒杆菌属 caeni 代表了微杆菌科内一个独特且分支很深的谱系。因此,我们还建议将这两个物种重新分类为新属,即地衣杆菌属,分别作为地衣杆菌属 soli comb。nov.和地衣杆菌属 caeni comb。nov.,并以 C. soli comb。nov.作为模式种。